Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.090
0.00 (0.00%)
Oct 6, 2026, 9:45 AM EDT - Market open
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $13.16 million as of October 6, 2026. Its market cap has decreased by -47.92% in one year.
Market Cap
13.16M
Enterprise Value
-10.99M
1-Year Change
-47.92%
Ranking
Category
Stock Price
$4.09
ChartMarket Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $13.16M, a decrease of -98.62%. That is a compound annual growth rate of -47.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 13.16M | -64.91% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 13.92M |
| IN8bio | 13.80M |
| Niki BioSolutions | 13.52M |
| Tempest Therapeutics | 13.42M |
| Vyome Holdings | 13.41M |
| Lisata Therapeutics | 13.25M |
| Daré Bioscience | 12.89M |
| BioLineRx | 12.59M |